RE:RE: Nee Amarin articleboozehound, you are sounding more desperate with every post. Why do you keep making stuff up? I have no idea how many warrants they have but do you think Arrow Capital (Alex Ruus) really would sell out when they just said they participated in a financing and says it could be a billion dollar company? Keep buying.
https://apps.cnbc.com/view.asp?country=US&uid=stocks/ownership&symbol=acst-v&country=CA
https://stockchase.com/company/view/4623/ACST-X
Pretty disappointing after last fall's announcement to have an Asian pharma company come in and get the rights to CaPre, their phase-3 development drug to treat cholesterol. It looked promising, but ACST hold off on the deal after a few new parties showed interest in CaPre. The market is disappointed the deal didn't happen and punished this stock. He believes this company could be worth $1 billion in two three years. The promise is still there, but you have to wait. Watch the phase 3 drug trials into next year.